EQ Form 144: Director reports multiple stock sales

EQ reported insider sales via Form 144 by Christine Zedelmayer.

Rhea-AI Filing Summary

EQ reported insider sales via Form 144 by Christine Zedelmayer. The filing lists multiple reported dispositions of Common Stock on 11/25/2025 (8,098 shares, $7,696.00), 12/12/2025 (23,804 shares, $31,897.00), 12/15/2025 (11,900 shares, $15,589.00), and 12/23/2025 (100,000 shares, $150,000.00).

The filing also lists planned sales of Common Stock issuable upon exercise of stock options dated 01/12/2022 (109,375 shares) and 01/02/2024 (76,562 shares), with sale method indicated as Cash.

Insights

Corporate Governance Specialist

Multiple reported insider dispositions by a single holder across late 2025.

The Form 144 excerpt lists specific reported sales by Christine Zedelmayer on 11/25/2025, 12/12/2025, 12/15/2025, and 12/23/2025 with stated share counts and dollar figures. These entries are routine regulatory notices required for certain post-sale statements.

Timing and aggregate impact on outstanding share count are not provided here; subsequent filings or company disclosures could clarify whether these represent significant dilution or secondary market activity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales did EQ report on Form 144 for Christine Zedelmayer?

The filing lists reported dispositions on 11/25/2025 (8,098 shares, $7,696.00), 12/12/2025 (23,804 shares, $31,897.00), 12/15/2025 (11,900 shares, $15,589.00), and 12/23/2025 (100,000 shares, $150,000.00).

Does the Form 144 show planned option-based sales for EQ?

Yes. The excerpt lists Common Stock to be sold from stock options dated 01/12/2022 (109,375 shares) and 01/02/2024 (76,562 shares), with sale method indicated as Cash in the provided lines.

Does the Form 144 state who received proceeds from these EQ sales?

The excerpt shows dollar amounts beside each reported disposition but does not state the recipient party for proceeds; the lines list proceeds figures such as $150,000.00 for the 12/23/2025 entry without naming payee arrangements.

Are these reported transactions indicative of company-issued shares or secondary sales?

The entries list dispositions of Common Stock and planned option-generated sales; the excerpt does not explicitly state whether shares were newly issued by the company or sold by existing holders in secondary transactions.

Where can I find more details about these EQ insider sales?

More detail typically appears in the full Form 144 filing and related Form 4 or company disclosures; those documents usually provide transaction mechanics, beneficial ownership and any footnote attributions for the reported sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001797818
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Equillium, Inc.
SEC File Number	001-38692
Address of Issuer	2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CALIFORNIA 92037
Phone	(858) 412-5302
Name of Person for Whose Account the Securities are To Be Sold	Zedelmayer Christine
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group 300 Park Ave 16th Floor New York NY 10022	185937	316092.00	60893283	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/12/2022	Stock Options	Issuer			109375	02/19/2026	Cash
Common Stock	01/02/2024	Stock Options	Issuer			76562	02/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christine Zedelmayer 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037	Common Stock	11/25/2025	8098	7696.00
Christine Zedelmayer 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037	Common Stock	12/12/2025	23804	31897.00
Christine Zedelmayer 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037	Common Stock	12/15/2025	11900	15589.00
Christine Zedelmayer 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA, CA 92037 LA JOLLA CA 92037	Common Stock	12/23/2025	100000	150000.00

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dominick Iadicicco, as a duly authorized representative of Maxim Group LLC., as attorney-in-fact for Christine Zedelmayer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)